Company Filing History:
Years Active: 1993
Title: Paul E Digard: Innovator in Herpes Simplex Virus Research
Introduction
Paul E Digard is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of virology, particularly in the study of herpes simplex virus (HSV). His innovative work has led to the development of a patent that addresses critical aspects of HSV replication.
Latest Patents
Paul E Digard holds a patent for "Inhibitors of herpes simplex virus replication." This patent describes an immunoassay for identifying an inhibitor of HSV DNA replication. The process involves providing a DNA polymerizing complex that includes two complex members: HSV DNA polymerase and UL42. The patent outlines a potential inhibitor that inhibits the binding of HSV DNA polymerase to UL42. The method includes mixing the complex members in the presence of the potential inhibitor and determining whether the potential inhibitor inhibits the formation of the complex. This innovative approach has the potential to advance therapeutic strategies against HSV.
Career Highlights
Paul E Digard is affiliated with Harvard College, where he conducts his research. His work has been instrumental in enhancing the understanding of viral mechanisms and developing potential therapeutic interventions. His dedication to research and innovation has positioned him as a key figure in the field of virology.
Collaborations
One of his notable collaborators is Donald M Coen. Their partnership has contributed to the advancement of research in herpes simplex virus and related areas.
Conclusion
Paul E Digard's contributions to the field of virology, particularly through his patent on HSV replication inhibitors, highlight his role as an innovator in medical research. His work continues to pave the way for future advancements in the treatment of viral infections.